BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19819061)

  • 1. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
    Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
    Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
    Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Methylation Status of CpG Sites within the HPV16 Long Control Region on HPV16-Positive Head and Neck Cancer Cells.
    Zhang C; Deng Z; Pan X; Uehara T; Suzuki M; Xie M
    PLoS One; 2015; 10(10):e0141245. PubMed ID: 26509736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
    Bhattacharjee B; Sengupta S
    Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
    Cheung JL; Cheung TH; Yu MY; Chan PK
    Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene characterization of E6 and E7 gene of human papillomavirus of 15 cervical cancer in Beijing].
    Ren Z; Wu HW; Song J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):88-90. PubMed ID: 20104743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].
    Niu XY; Peng ZL; Wang H
    Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation.
    Badal S; Badal V; Calleja-Macias IE; Kalantari M; Chuang LS; Li BF; Bernard HU
    Virology; 2004 Jul; 324(2):483-92. PubMed ID: 15207633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
    Schmitt M; Dalstein V; Waterboer T; Clavel C; Gissmann L; Pawlita M
    Cancer Res; 2010 Jan; 70(1):249-56. PubMed ID: 20028865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
    Donalisio M; Cornaglia M; Landolfo S; Lembo D
    Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
    Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
    Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.